10/27/2008 | CV | Ranbaxy holders may now convert 0% convertibles
|
9/21/2006 | BT | Ipca, Ranbaxy to develop generics for U.S. market
|
9/21/2006 | BT | Ranbaxy gets FDA approval to sell Furosemide tablets
|
9/13/2006 | BT | Pfizer's Lipitor patent upheld in Dutch court
|
9/12/2006 | BT | Ranbaxy to sell Avessa for asthma in India
|
9/11/2006 | BT | Ranbaxy gets FDA approval to sell generic Imodium
|
8/29/2006 | BT | Ranbaxy's atorvastatin patents do not infringe Pfizer's Lipitor patents, Norwegian court says
|
8/14/2006 | BT | Ranbaxy to market triple combination antiretrovirals in India
|
8/4/2006 | BT | Ranbaxy gets tentative FDA approval to market oral schizophrenia drug
|
8/2/2006 | BT | Pfizer, Ranbaxy: both sides win one part of patent lawsuit for atorvastatin
|
7/19/2006 | BT | Ranbaxy signs licensing, supply agreement for the Canadian market
|
7/18/2006 | BT | Ranbaxy acquires Mundogen generic business of GlaxoSmithKline in Spain
|
7/17/2006 | BT | Ranbaxy, Nippon launch generic Clarith, Lamisil tablets in Japan
|
6/9/2006 | BT | Ranbaxy to market zonisamide capsules in United States
|
6/7/2006 | BT | Zenotech, Ranbaxy to partner on 11 generic oncology drugs
|
6/2/2006 | BT | Ranbaxy gets FDA approval to market Doxycycline tablets
|
5/24/2006 | BT | Ranbaxy gains pre-qualification for more antiretroviral products
|
5/24/2006 | BT | Ranbaxy in-licenses NDDS analgesic molecule from Ethypharm
|
5/17/2006 | BT | Ranbaxy in-licenses asthma drug from Eurodrug Laboratories
|
4/25/2006 | BT | Ranbaxy wins atorvastatin suit in Austria; Pfizer to defend Lipitor patent in other countries
|
3/30/2006 | BT | Ranbaxy acquires generics maker Ethimed
|
3/29/2006 | BT | Ranbaxy acquires Terapia for $324 million
|
3/28/2006 | BT | Ranbaxy to acquire unbranded generic business of GlaxoSmithKline in Italy
|
3/20/2006 | BT | Ranbaxy buys rights, assets for Senetek's autoinjector
|
3/9/2006 | BT | Ranbaxy Laboratories enters into strategic alliance with Zenotech
|
2/15/2006 | BT | Market Commentary: Pfizer peddling ¥50 billion bonds; Amgen up out of chute; Adolor at bat; Ranbaxy taps convertibles market
|
2/15/2006 | BTCVEM | New Issue: India's Ranbaxy Labs sells $440 million 0% convertibles to yield 4.8%, up 60%
|
12/22/2005 | BT | Cephalon, Ranbaxy settle patent infringement lawsuit over Provigil
|
11/30/2005 | BT | Ranbaxy introduces two new anti-HIV products as part of World AIDS Day activities
|
11/22/2005 | BT | Market Commentary: Pain Therapeutics falls on poor trial data; Sinovac off of profit taking; Point Therapeutics rises
|
11/11/2005 | BT | Ranbaxy ups equity stake in Nihon Pharmaceutical to 50%
|
9/9/2005 | BTCV | Ranbaxy Laboratories aims for listing on U.S. exchange, board approves financing, borrowing
|